Switch theme
Sign up to access all valuation multiples
Papoutsanis SA manufactures food, personal care and household cleaning products. The company's products include soap items, cosmetic, shower caps and sewing kits, vanity sets, paper cases, dental kits, shaving set among others.
1960
n/a
LTM Revenue $77.8M
LTM EBITDA $12.6M
$106M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Papoutsanis has a last 12-month revenue of $77.8M and a last 12-month EBITDA of $12.6M.
In the most recent fiscal year, Papoutsanis achieved revenue of $74.1M and an EBITDA of $11.3M.
Papoutsanis expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Papoutsanis valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $69.7M | $74.1M | XXX | XXX | XXX |
| Gross Profit | $19.4M | $23.8M | XXX | XXX | XXX |
| Gross Margin | 28% | 32% | XXX | XXX | XXX |
| EBITDA | $9.7M | $11.3M | XXX | XXX | XXX |
| EBITDA Margin | 14% | 15% | XXX | XXX | XXX |
| Net Profit | $3.4M | $4.6M | XXX | XXX | XXX |
| Net Margin | 5% | 6% | XXX | XXX | XXX |
| Net Debt | $19.6M | $19.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 19, 2025, Papoutsanis's stock price is EUR 3 (or $3).
Papoutsanis has current market cap of EUR 72.5M (or $81.1M), and EV of EUR 94.7M (or $106M).
See Papoutsanis trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $106M | $81.1M | XXX | XXX | XXX | XXX | $0.23 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 19, 2025, Papoutsanis has market cap of $81.1M and EV of $106M.
Papoutsanis's trades at 1.4x LTM EV/Revenue multiple, and 8.4x LTM EBITDA.
Analysts estimate Papoutsanis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Papoutsanis and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $106M | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 9.4x | XXX | XXX | XXX |
| P/E | 13.7x | XXX | XXX | XXX |
| P/E/Growth | 0.7x | XXX | XXX | XXX |
| EV/FCF | -55.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPapoutsanis's NTM/LTM revenue growth is 11%
Papoutsanis's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Papoutsanis's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Papoutsanis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Papoutsanis and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | XXX | XXX | XXX |
| EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 0% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 0% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Mediterra | XXX | XXX | XXX | XXX | XXX | XXX |
| Yalco Constantinoy | XXX | XXX | XXX | XXX | XXX | XXX |
| Hindustan Unilever | XXX | XXX | XXX | XXX | XXX | XXX |
| Godrej Consumer Products | XXX | XXX | XXX | XXX | XXX | XXX |
| Henkel | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Papoutsanis acquired XXX companies to date.
Last acquisition by Papoutsanis was XXXXXXXX, XXXXX XXXXX XXXXXX . Papoutsanis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Papoutsanis founded? | Papoutsanis was founded in 1960. |
| Where is Papoutsanis headquartered? | Papoutsanis is headquartered in Greece. |
| Is Papoutsanis publicy listed? | Yes, Papoutsanis is a public company listed on ATH. |
| What is the stock symbol of Papoutsanis? | Papoutsanis trades under PAP ticker. |
| When did Papoutsanis go public? | Papoutsanis went public in 1972. |
| Who are competitors of Papoutsanis? | Similar companies to Papoutsanis include e.g. Mediterra, Yalco Constantinoy, Hindustan Unilever, Godrej Consumer Products. |
| What is the current market cap of Papoutsanis? | Papoutsanis's current market cap is $81.1M |
| What is the current revenue of Papoutsanis? | Papoutsanis's last 12-month revenue is $77.8M. |
| What is the current EBITDA of Papoutsanis? | Papoutsanis's last 12-month EBITDA is $12.6M. |
| What is the current EV/Revenue multiple of Papoutsanis? | Current revenue multiple of Papoutsanis is 1.4x. |
| What is the current EV/EBITDA multiple of Papoutsanis? | Current EBITDA multiple of Papoutsanis is 8.4x. |
| What is the current revenue growth of Papoutsanis? | Papoutsanis revenue growth between 2023 and 2024 was 6%. |
| Is Papoutsanis profitable? | Yes, Papoutsanis is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
